Streetwise Reports' Article Archives — May 2020 back to current month (36)

AI Firm Develops Tool That Helps Radiologists Diagnose COVID-19 (05/30/2020)

Patriot One Technologies and its partners have created a model that automatically calculates, from a radiological scan, the degree of a patient's affected lungs, a COVID-19 indicator.


Small-Cap Pharma Fast-Tracking Repurposed Drug for Covid-19 (05/27/2020)

Algernon Pharmaceuticals is quickly moving ahead with a multinational Phase 2b/3 trial for Ifenprodil.


Surgical Equipment Firm Delivers Innovative Imaging Systems to Leading Urologists (05/27/2020)

Imagin Medical delivered two functional i/Blue™ Imaging Systems for use in conducting in vivo studies and virtual demonstrations for evaluation by leading urologists.


Biotech's 'Multiple Sclerosis Therapy Shows Improvement in Disability' (05/27/2020)

Atara Biotherapeutics' clinical trial design and results are reviewed in a ROTH Capital Partners report.


Biotech Identifies Antibody with 100% SARS-CoV-2 Inhibition (05/27/2020)

The goal of Sorrento Therapeutics to develop a Covid-19 antibody cocktail, including its progress, next steps and market opportunity, is reviewed in a Dawson James report.


Mersana Therapeutics Trades 60% Higher on Positive Phase 1 Ovarian Cancer Trial Data (05/27/2020)

Shares of Mersana Therapeutics reached a new 52-week high price after the company reported positive interim data from the expanded portion of its Phase 1 study of XMT-1536 for treatment of ovarian cancer.


Novavax Shares Rise 9% Upon Initiating Phase 1/2 COVID-19 Vaccine Clinical Trial (05/26/2020)

Novavax shares traded higher after the company reported it enrolled the first participants in its Phase 1 clinical study of NVX CoV2373.


Vertically Integrated Hemp/CBD Player Sweet Earth Holdings Debuts on CSE (05/26/2020)

With CBD showing some promise against Covid-19 and cannabis stocks rising, Peter Epstein of Epstein Research discusses the market with Sweet Earth Holdings executives.


Positive Test Results in Dairy Cows Lead to Upsized Livestock Supplement Order (05/21/2020)

With this sale, Avivagen's antibiotics-free, immune-boosting feed additive enters the Mexican market.


Biotech Partnership to Develop Diagnostic Assay for Alzheimer's Disease (05/20/2020)

With its work on this and a SARS-CoV-2 test, ProMIS Neurosciences is applying its technology platform in new ways.


Surface Oncology Shares Trade Up 40% on Phase 1 Study Plans for SRF617 Combined with Merck's KEYTRUDA (05/20/2020)

Shares of Surface Oncology set a new 52-week high price after the company reported that it is partnering with Merck & Co. in an immuno-oncology study of SRF617, targeting CD39 in combination with KEYTRUDA® (pembrolizumab) in solid tumor patients.


US Biopharma to Launch Phase 3 Trial in Bacterial Vaginosis (05/20/2020)

Daré Bioscience's study, its prospects and the indication's U.S. market opportunity are discussed in a ROTH Capital Partners report.


Arbutus Biopharma Trades 25% Higher on Phase 1 Hepatitis B Results (05/19/2020)

Shares of Arbutus Biopharma traded higher after the company reported significant and continuous reduction in HBsAg in 12 chronic hepatitis B subjects using 60 mg dosage of its AB-729 drug.


Surgical Imaging Company Provides Update on COVID-19 Impact (05/18/2020)

Imagin Medical reported that its actions have mitigated the impact of the coronavirus on its business operations.


Moderna Shares Rise 25% on Positive Phase 1 Coronavirus Vaccine Trial Data (05/18/2020)

Shares of Moderna Inc. traded higher, setting a new 52-week high price, after the firm reported positive interim results in its Phase 1 study of mRNA Vaccine (mRNA-1273) against SARS-CoV-2.


Biopharma Seeks Ethics Approval in Australia to Test COVID-19 Treatment (05/18/2020)

Algernon Pharmaceuticals intends to test a repurposed drug for this indication, in a trial in three countries.


Cannabis Cultivator Shifts Focus to Commercializing Technology (05/18/2020)

Sproutly Canada has received capital investment from Infusion Biosciences.


Aurora Cannabis Shares Catch Fire on Positive Q3/20 Financial Results (05/15/2020)

Shares of Aurora Cannabis traded 60% higher after the company reported an 18% rise in net revenue, which included a 24% increase in consumer sales versus to the prior quarter.


Biotech Expands Antibody Research Across Multiple Neurodegenerative Diseases and Covid-19 (05/14/2020)

ProMIS Neurosciences advances its various antibody programs related to neurodegenerative diseases and viral infections such as Covid-19.


Allogene Therapeutics Shares Climb 30% on Phase 1 Relapsed/Refractory NHL Study Data (05/14/2020)

Shares of Allogene Therapeutics traded higher and reached a new 52-week high price after the company reported initial results from its Phase 1 relapsed/refractory non-Hodgkin lymphoma trial.


Acceleration of COVID-19 Vaccine Programs Could Benefit U.S. Biotech (05/13/2020)

The development timeline for Inovio Pharmaceuticals' coronavirus vaccine candidate is discussed in an H.C. Wainwright & Co. report.


Biotech Advances Accurate SARS CoV-2 Antibodies Detection Test (05/13/2020)

Testing and validation of ProMIS Neurosciences' antibody targets will be conducted over the coming weeks.


MyoKardia Shares Get a Jolt from Positive Phase 3 HCM Clinical Trial Results (05/11/2020)

Shares of MyoKardia traded 60% higher, setting a new 52-week high price, after the company reported that it met all primary and secondary endpoints in the Phase 3 EXPLORER study of mavacamten in treatment of obstructive hypertrophic cardiomyopathy.


Pharmaceutical Firm Gains Ethics Approval for Phase 2 Human IPF and Chronic Cough Trial (05/10/2020)

Algernon Pharmaceuticals reported that it has received ethics approval in Australia for a Phase 2 human clinical study of NP-120 (Ifenprodil) for use in treatment of idiopathic pulmonary fibrosis and chronic cough.


Protagonist's Shares Nearly Double After Reporting Q1 Earnings and Positive Phase 2 Trial Results (05/08/2020)

Shares of Protagonist Therapeutics traded higher and reached a new 52-week high price after the company released Q1/20 financial results and positive data from its Phase 2 study of PTG-300 in patients with polycythemia vera, a type of blood cancer.


Canadian Firm Partners for US Sales of Its Telehealth Platform (05/07/2020)

This arrangement will bolster the use of CloudMD Software & Services' software in the United States.


Building a Better Covid-19 Antibody Test (05/06/2020)

ProMIS is harnessing its unique technology platform to develop a more error-free antibody test.


California Biotech Partners for Manufacture of COVID-19 Vaccine Candidate (05/06/2020)

Arcturus Therapeutics Holdings' arrangement is explained and commented on in an H.C. Wainwright & Co. report.


Biotech Develops Antagonists for Protein Tied to Neurodegenerative Diseases (05/06/2020)

ProMIS Neurosciences' antagonists prevent dysfunctional protein aggregation.


Horizon Therapeutics Shares Rise 15% on Strong Q1 Results and Raised F/Y Sales Guidance (05/06/2020)

Shares of Horizon Therapeutics traded higher setting a new 52-week high price after the company reported a 27% y-o-y increase in net sales for Q1/20 and raised FY/20 net sales guidance.


Firm Partners with Canada's Largest Western Grocery Chain and Leading Community Pharmacy to Pilot In-Store Virtual Patient Care (05/05/2020)

CloudMD announced that it is partnering with Save-On-Foods grocery stores and Pure Integrative Pharmacy to pilot on demand, integrated virtual patient care through telemedicine kiosks placed in pharmacies' existing consult rooms.


Alexion's Buyout of Portola Pharmaceuticals Gets Investors' Blood Flowing (05/05/2020)

Shares of Portola Pharmaceuticals traded 130% higher after the company reported that it has received an $18 per share buyout offer from Alexion Pharmaceuticals.


Telehealth Platform Added to Vendor Lists of Leading Medical Associations (05/04/2020)

Use of CloudMD Software & Services' health solution is seeing significant growth.


Firm Creates Novel Intrabodies for ALS and Other Neurodegenerative Diseases (05/04/2020)

ProMIS Neurosciences reported it has generated novel intrabodies that are highly selective for misfolded forms of TAR DNA-binding protein 43 implicated in several neurologic disorders.


Stemline Shares Take Off on $677 Million Buyout Offer by Global Pharmaceutical Firm (05/04/2020)

Shares of Stemline Therapeutics traded 150% higher after the company reported that it has entered into a definitive agreement to be acquired by Italy's Menarini Group in a deal valued at up to $677 million.


Seattle Genetics Shares Trade Higher on Q1/20 Earnings and 22% Growth in ADCETRIS Sales (05/01/2020)

Seattle Genetics shares traded 8% higher, reaching a new 52-week high, after the company reported Q1/20 financial results which included a 10% y-o-y increase in net revenues fueled by a 22% increase in sales of ADCETRIS® and a strong debut for PADCEV™ in its first full quarter of sales.


More Archives

2024Jun May Apr Mar Feb Jan

2023Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2022Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2021Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2020Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2019Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Get Our Streetwise Reports' Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

Notable Quotes